Caredx Inc Stock
€14.07
Your prediction
Caredx Inc Stock
CareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Pros and Cons of Caredx Inc in the next few years
Pros
Cons
Performance of Caredx Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Caredx Inc | -3.420% | 8.234% | 9.797% | -30.094% | -30.509% | 5.451% | -69.417% |
| Ardelyx Inc. | 0.990% | 4.175% | 16.775% | 6.870% | 1.511% | 326.108% | 2.983% |
| Krystal Biotech | 1.580% | 2.484% | 8.812% | 8.074% | 15.210% | 133.800% | - |
| Evolus Inc | -2.440% | 1.653% | 11.818% | -41.981% | -41.429% | -15.753% | 107.840% |
News
CareDx (CDNA) EPS Beats Sales Gain 14%
CareDx (NASDAQ:CDNA), a molecular diagnostics company specializing in transplant care solutions, released its results for the second quarter of fiscal 2025 on August 6, 2025. The big news from the
